Intarcia Therapeutics

Intarcia is on track to file the drug-device combo for FDA approval in 2016
Intarcia's product requires only a once-a-year implantation
Intarcia CEO Kurt Graves said in a statement. "... The prospect of bringing a totally new therapeutic approach to the market
The Boston-headquartered Intarcia believes its lead therapy is poised to disrupt the market for Type 2 diabetes treatments


Oh yeah !!

 

BS on every listed lies.

And the only disruption has been self-inflicted FDA rejection of NDA in Sept 2017 followed by FDA cease and desist of the on-going trials due to stability and sterility failures in Jan 2018. In the meantime, Novo's oral GLP-1 and generic exenatide injections will pretty much kill ITCA that is IF that POS ever gets approved which is fat chance to say the least.

PS - How much cash and cash equivalent do they have left? Any news on investor lawsuits?

 

Tis the holiday season. Give the gift that keeps on giving. Documents from the fund raising period documenting claims of superior compliance, once a year administration, disrupting diabetes, launch in in 2016, 2017, 2018, 2019, sales - since none of these have occurred and since it was clear these would not occur... Only you can prevent fraud. Share the documents with investigators, with regulators. Investor lawsuits, Licensing arbitration, Regulatory oversight. It’s time to come clean and admit the truth.

 

All hail the CEO with no clothes ! Please fawn and bow. He one disruptin mofo. Ask investors are you disrupted yet ?

 

march 9 ? For the launch of the Titanic the worlds most unsinkable boat.

What’s disappeared ? The claim of “once a year” hey where did that go ?? The claim of biology and chemistry ? The CEO seems to have lost the claims of an degree ?? Where did all the claims go going to business school go ???

 

Boston, MA – April 27, 2015 – Intarcia Therapeutics, Inc. today announced the closing of a $225 million synthetic royalty financing with an equity conversion option at a $5.5 billion Company valuation.

Under the terms of the deal, investors have purchased Convertible Limited Recourse Notes from Intarcia and are entitled to receive quarterly payments equal to 1.5% of future global net sales of ITCA 650 until the notes mature or are fully paid. Investors have the option, commencing upon U.S. regulatory approval of ITCA 650 and ending on the later of the second anniversary of the approval or December 31, 2019, to convert their synthetic royalty interests into Intarcia common stock at a conversion price corresponding to an equity valuation of $5.5 billion.

“Our vision and driving belief remains that we can and must discover a new and game-changing way to deliver better medicines, and better health outcomes, with just once- or twice-yearly dosing for chronic diseases,” said Kurt Graves, Chairman, President and CEO of Intarcia. “Transforming the status quo trends around poor control, poor compliance and costly outcomes in diabetes is mission critical around the world. Our aim with ITCA 650 is to deliver a once-yearly medicine that succeeds beyond the key efficacy and compliance shortcomings that the majority of patients experience when trying to stick with life-long pills and self-injections,” added Graves. “This large and innovative financing announced today is another first-of-its-kind in our industry, and it shows investor confidence in our pivotal data, our partnerships and our overall approach to a huge unmet need and opportunity in type 2 diabetes. We’ve now secured the financial means to keep 100 percent control of the U.S. commercialization of ITCA 650, with funds needed all the way through the planned approval and early launch period in 2017.

 

So which suckas playing with OPM (other people/s money) bought the convertible notes? Oh wait 2nd anniversary in 3 weeks to convert to non-existent stocks? ROFL

 

Why is this so funny to you?

 

Because there are some mighty sick puppies posting on this board. Indeed this whole fiasco is a tragedy.

 

at least we kept 100% of the US commercial opportunity just like it sez...

Hey it ain’t like we got nuthin

Oh wait...

 

Because so many investment schmucks got fleeced by fatcat KG and his ex-henchman big O. And yes quite amusing really to see this turd go down the tubes and into BK oblivion, soon.

 

Vous aussi idiote?

 

\

Hey this sick pup wants to know when Intarica is projected to run out of cash, both best and worst cases. How much cash and cash equivalents does it have?

I know this sick pup is asking a lot and understand that as a private company ran by the emperor KG they can hide behind the outhouse but surely someone has/have to scoop out the sticky excrements overflowing the cesspool called Intarcia?

 

“Telling a lie is an act with a sharp focus. It is designed to insert a particular falsehood at a particular point in a set or system of beliefs, in order to have that point occupied by the truth. This requires a degree of craftsmanship, in which the teller of the lie submits to objective constraints imposed by what he takes to be the truth. The liar is inescapably concerned with truth-values. In order to invent a lie at all, he must think he knows what is true. And in order to invent an effective lie, he must design his falsehood under the guidance of that truth.

On the other hand, a person who takes to bullshit his way through has much more freedom. His focus is panoramic rather than particular. He does not limit himself to inserting a certain falsehood at a specific point, and thus he is not constrained by the truths surrounding that point or intersecting it. He is prepared, so far as is required, to fake the context as well. This freedom from the constraints to which the liar must submit does not necessarily mean, of course, that his task is easier than the task of the liar. But the mode of creativity upon which it relies is less analytical and less deliberative than that which is mobilized in lying. It is more expansive and independent, with more spacious opportunities for improvisation, color and imaginative play. This is less a matter of craft than of art. Hence the familiar notion of the 'bullshit artist'.”
― Harry G. Frankfurt,

Ah such artistry is Intarcia

 

Holidays are a good time for reflection. Why all the exaggeration about what Intarcia can and will do ?

How narcissistic CEOs put companies at risk
https://www.cnn.com/2018/11/05/success/narcissist-ceo/index.html

Narcissistic CEOs Weaken Collaboration and Integrity
https://www.gsb.stanford.edu/insights/narcissistic-ceos-weaken-collaboration-integrity

11 signs your boss may be a narcissist, including lots of swearing and a love of being in control
https://www.businessinsider.com/signs-your-boss-is-a-narcissist-2015-4

Narcissistic Leaders—The Destructive Lies They Tell Themselves And Others
https://www.forbes.com/sites/kathycaprino/2019/06/07/narcissistic-leadersthe-destructive-lies-they-tell-themselves-and-others/#53dc7e451b67

Narcissistic CEOs Can Mean Big Legal Bills
https://www.gsb.stanford.edu/insights/narcissistic-ceos-can-mean-big-legal-bills

 

Wait are you inferring that the ex-college footballer leader is a narcissistic liar? ROFL

 

Dude it was midget football and he got the Captain's Award for being a cheerleader

 

Besides the Dude being a midget, and management being in disarray, and alleged fraudulent financial practices, yada yada yada... What is the latest on the FDA filing?

 

The Feds must have accepted the revised NDA which took over 2 years to completely rewrite and remediate the PAI observations. But there looms another PAI and check every word in the submission.

The best case for this pig is that the NDA gets approved in a year but challenges loom whether CMS (Medicare) and payers will cover the treatment with most payers initially consider it as some kind of experimental treatment and NOT cover/reimburse. It can take months for the CMS to provide coverage code and sometimes demand additional clinical studies.

And based on the awful dropout rate during the clinical trial with the patients facing 3 to 4 implant surgeries 1st year - it's doomed...

In the meantime, mother pig is bleeding/burning a lot of money.

 

Sorry you didn't get the job. Major build for launch in April. Medici is expected to be a multibillion dollar blockbuster. Medici cures the biggest problem in Diabetes - non-compliance. Patients are being stock piled so Physicians can immediately switch them on approval. Conservative Wall Street expectations are $100 Million of sales in the first quarter after launch (ie, by June 28, 2020). Medici sales will exceed $500 Million for the second quarter of 2021. Marketing genius, Time2Disrupt

You may have been passed over for sales, consider reapplying many jobs available for reimbursement and patient experience.